Security posture
The short version
On-premise, by default
Every product installs inside your institution's network. No cloud component carries PHI.
No outbound PHI
No telemetry, no auto-update over the internet, no patient data ever crosses the firewall.
Audit-ready
Every transformation is logged. Re-identification linking files stay on your storage.
Aligned with HIPAA
Because PHI processing happens on infrastructure you control, your institution's existing HIPAA controls apply directly.
FDA / 510(k) status
Two cleared products. The rest is research-use or in-development
- INTContour — 510(k) K212274 · cleared 2022
AI-assisted auto-contouring for radiation oncology. - INTDose — 510(k) K213137 · cleared 2022
Monte Carlo dose verification for radiation treatment planning. - OncoAI Suite, QuantBrain — Not FDA-cleared. Research-use only. Outputs are not for diagnostic or clinical decision-making purposes.
- CuratAI — Not a medical device. Research-use data-curation platform. Not a diagnostic, treatment-planning, or clinical decision-support tool.
For product-specific deployment architecture, data-handling details, BAAs, DICOM Conformance Statements, or InfoSec questionnaire responses, contact [email protected]. See each product page for its own on-premise specifics.